chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Headache, Influenza like illness, Myalgia
Clinical narrative: Drowsy; Flu like symptoms; Warm body; Fatigue; Body Aches; Headache on the Right Side of Head, Headache in the mid section of Head; Mild Sore Injection Site (After 2nd dose); Mild Numbness on the Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PARAESTHESIA (Mild Numbness on the Injection Site), SOMNOLENCE (Drowsy), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING HOT (Warm body) and FATIGUE (Fatigue) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced VACCINATION SITE PARAESTHESIA (Mild Numbness on the Injection Site) and VACCINATION SITE PAIN (Mild Sore Injection Site (After 2nd dose)). On 31-Mar-2021, the patient experienced SOMNOLENCE (Drowsy), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING HOT (Warm body), FATIGUE (Fatigue), MYALGIA (Body Aches) and HEADACHE (Headache on the Right Side of Head, Headache in the mid section of Head). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 31-Mar-2021, VACCINATION SITE PARAESTHESIA (Mild Numbness on the Injection Site) and VACCINATION SITE PAIN (Mild Sore Injection Site (After 2nd dose)) had resolved. At the time of the report, SOMNOLENCE (Drowsy), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING HOT (Warm body), FATIGUE (Fatigue), MYALGIA (Body Aches) and HEADACHE (Headache on the Right Side of Head, Headache in the mid section of Head) outcome was unknown.            Concomitant medications were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Somnolence, Vaccination site pain, Vaccination site paraesthesia
Clinical narrative: Drowsy; Flu like symptoms; Warm body; Fatigue; Body Aches; Headache on the Right Side of Head, Headache in the mid section of Head; Mild Sore Injection Site (After 2nd dose); Mild Numbness on the Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PARAESTHESIA (Mild Numbness on the Injection Site), SOMNOLENCE (Drowsy), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING HOT (Warm body) and FATIGUE (Fatigue) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced VACCINATION SITE PARAESTHESIA (Mild Numbness on the Injection Site) and VACCINATION SITE PAIN (Mild Sore Injection Site (After 2nd dose)). On 31-Mar-2021, the patient experienced SOMNOLENCE (Drowsy), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING HOT (Warm body), FATIGUE (Fatigue), MYALGIA (Body Aches) and HEADACHE (Headache on the Right Side of Head, Headache in the mid section of Head). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 31-Mar-2021, VACCINATION SITE PARAESTHESIA (Mild Numbness on the Injection Site) and VACCINATION SITE PAIN (Mild Sore Injection Site (After 2nd dose)) had resolved. At the time of the report, SOMNOLENCE (Drowsy), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING HOT (Warm body), FATIGUE (Fatigue), MYALGIA (Body Aches) and HEADACHE (Headache on the Right Side of Head, Headache in the mid section of Head) outcome was unknown.            Concomitant medications were not provided.
Sex: U
Vaccine: COVID19
Symptoms: Blister
Clinical narrative: 3 blister on the finger after receiving 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of BLISTER (3 blister on the finger after receiving 1st dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLISTER (3 blister on the finger after receiving 1st dose). At the time of the report, BLISTER (3 blister on the finger after receiving 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The first blister disappeared after 24 hours, and the rest of the 2 disappeared after 2-3 days. Concomitant medications were not provided. Treatment information was not reported
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain at injection left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection left arm) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection left arm). On 02-Mar-2021, VACCINATION SITE PAIN (Pain at injection left arm) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment information was not provided.  Concomitant product use was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Myalgia, Pyrexia
Clinical narrative: aches/soreness; headaches; Fever 102F; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (aches/soreness), HEADACHE (headaches), PYREXIA (Fever 102F) and CHILLS (Chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced MYALGIA (aches/soreness), HEADACHE (headaches), PYREXIA (Fever 102F) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, MYALGIA (aches/soreness), HEADACHE (headaches), PYREXIA (Fever 102F) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Mar-2021, Body temperature: 102f (High) 102F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Limb discomfort, Pain in extremity
Clinical narrative: I can't move my left leg.; It's painful from my knee down; My left arm is painful; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (I can't move my left leg.), ARTHRALGIA (It's painful from my knee down) and PAIN IN EXTREMITY (My left arm is painful) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced LIMB DISCOMFORT (I can't move my left leg.), ARTHRALGIA (It's painful from my knee down) and PAIN IN EXTREMITY (My left arm is painful). The patient was treated with OXYCODONE HYDROCHLORIDE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;PARACETAMOL]) for Pain, at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (I can't move my left leg.), ARTHRALGIA (It's painful from my knee down) and PAIN IN EXTREMITY (My left arm is painful) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product was Diabetes medications. Action taken with mRNA-1273 in response to the events was Not Applicable.   This case was linked to MOD-2021-051815 (Patient Link).
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Vaccination site pain
Clinical narrative: NO redness; 1st dose gave just sore arm; This spontaneous case was reported by a consumer and describes the occurrence of NO ADVERSE EVENT (NO redness) and VACCINATION SITE PAIN (1st dose gave just sore arm) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L2/(Z)0/(O)A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PAIN (1st dose gave just sore arm). On an unknown date, the patient experienced NO ADVERSE EVENT (NO redness). On 18-Jan-2021, VACCINATION SITE PAIN (1st dose gave just sore arm) had resolved. At the time of the report, NO ADVERSE EVENT (NO redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details were provided. No treatment medication details were provided.   This case was linked to MOD-2021-057481 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Vaccination site swelling, Vaccination site warmth
Clinical narrative: redness; sore arm; injection site was hot" and "swollen".; injection site was hot" and "swollen".; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness), PAIN IN EXTREMITY (sore arm), VACCINATION SITE WARMTH (injection site was hot" and "swollen".) and VACCINATION SITE SWELLING (injection site was hot" and "swollen".) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol and Seasonal allergy.   On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (redness), PAIN IN EXTREMITY (sore arm), VACCINATION SITE WARMTH (injection site was hot" and "swollen".) and VACCINATION SITE SWELLING (injection site was hot" and "swollen".). At the time of the report, ERYTHEMA (redness), PAIN IN EXTREMITY (sore arm), VACCINATION SITE WARMTH (injection site was hot" and "swollen".) and VACCINATION SITE SWELLING (injection site was hot" and "swollen".) outcome was unknown. Not Provided          Concomitant medication included cholesterol medication, seasonal allergies medication. Treatment information was not reported.   This case was linked to MOD-2021-022565 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pruritus, Skin reaction
Clinical narrative: her tip of the head area to her ankles ( scalp, neck, torso) are all itchy, feels the need to itch; Delayed reaction; unusual fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (her tip of the head area to her ankles ( scalp, neck, torso) are all itchy, feels the need to itch), SKIN REACTION (Delayed reaction) and FATIGUE (unusual fatigue) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Osteoporosis. Concomitant products included IBANDRONATE SODIUM (BONIVA) from 06-Mar-2021 to an unknown date for Osteoporosis.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced PRURITUS (her tip of the head area to her ankles ( scalp, neck, torso) are all itchy, feels the need to itch), SKIN REACTION (Delayed reaction) and FATIGUE (unusual fatigue). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PRURITUS (her tip of the head area to her ankles ( scalp, neck, torso) are all itchy, feels the need to itch), SKIN REACTION (Delayed reaction) and FATIGUE (unusual fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported that next dose of ibandronate sodium for osteoporosis is due on 03-Apr-2021.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Lip swelling, Pyrexia, Rash
Clinical narrative: Rash went across my chest and up my neck and was burning and itched; Lips puffed up; Sore Arm; fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (Rash went across my chest and up my neck and was burning and itched), LIP SWELLING (Lips puffed up), ARTHRALGIA (Sore Arm) and PYREXIA (fever) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 008B21A) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A), OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC), SALBUTAMOL (ALBUTEROL HFA), EPINEPHRINE (EPIPEN), POTASSIUM CHLORIDE, HYDROCHLOROTHIAZIDE, AMLODIPINE, LOSARTAN, ISOSORBIDE MONONITRATE, ACETYLSALICYLIC ACID (ASPIRIN 81), METOPROLOL SUCCINATE and GABAPENTIN for an unknown indication.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced RASH (Rash went across my chest and up my neck and was burning and itched), LIP SWELLING (Lips puffed up), ARTHRALGIA (Sore Arm) and PYREXIA (fever). At the time of the report, RASH (Rash went across my chest and up my neck and was burning and itched), LIP SWELLING (Lips puffed up), ARTHRALGIA (Sore Arm) and PYREXIA (fever) outcome was unknown.            Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to US-MODERNATX, INC.-MOD-2021-063879 (E2B Linked Report).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. US-MODERNATX, INC.-MOD-2021-063879:Second dose vaccination
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Myalgia, Nausea, Vaccination site pain
Clinical narrative: doesn't feel good; Vaccination site pain; Body ache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (doesn't feel good), VACCINATION SITE PAIN (Vaccination site pain), MYALGIA (Body ache) and NAUSEA (nausea) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History Information was reported.     On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 30-Mar-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain), MYALGIA (Body ache) and NAUSEA (nausea). On 31-Mar-2021, the patient experienced FEELING ABNORMAL (doesn't feel good). At the time of the report, FEELING ABNORMAL (doesn't feel good), VACCINATION SITE PAIN (Vaccination site pain), MYALGIA (Body ache) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included unspecified anxiety medication.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: F/U Received. No new information.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Dizziness, Eye pain, Fatigue
Clinical narrative: dizziness; painful eyes; sore arm; coughing; chills; Fever; nausea; Body aches; fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), EYE PAIN (painful eyes), PAIN IN EXTREMITY (sore arm), COUGH (coughing) and CHILLS (chills) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced DIZZINESS (dizziness), EYE PAIN (painful eyes), PAIN IN EXTREMITY (sore arm), COUGH (coughing), CHILLS (chills), PYREXIA (Fever), NAUSEA (nausea), MYALGIA (Body aches), FATIGUE (fatigue) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYNELOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizziness), EYE PAIN (painful eyes), PAIN IN EXTREMITY (sore arm), COUGH (coughing), CHILLS (chills), PYREXIA (Fever), NAUSEA (nausea), MYALGIA (Body aches) and FATIGUE (fatigue) had resolved and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea, Pain in extremity, Pyrexia
Clinical narrative: dizziness; painful eyes; sore arm; coughing; chills; Fever; nausea; Body aches; fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), EYE PAIN (painful eyes), PAIN IN EXTREMITY (sore arm), COUGH (coughing) and CHILLS (chills) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced DIZZINESS (dizziness), EYE PAIN (painful eyes), PAIN IN EXTREMITY (sore arm), COUGH (coughing), CHILLS (chills), PYREXIA (Fever), NAUSEA (nausea), MYALGIA (Body aches), FATIGUE (fatigue) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYNELOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizziness), EYE PAIN (painful eyes), PAIN IN EXTREMITY (sore arm), COUGH (coughing), CHILLS (chills), PYREXIA (Fever), NAUSEA (nausea), MYALGIA (Body aches) and FATIGUE (fatigue) had resolved and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Flushing, Hypoaesthesia
Clinical narrative: feeling numbness in her face; Felt warm feeling in her left cheek; Flushing; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (feeling numbness in her face), FEELING HOT (Felt warm feeling in her left cheek) and FLUSHING (Flushing) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced HYPOAESTHESIA (feeling numbness in her face), FEELING HOT (Felt warm feeling in her left cheek) and FLUSHING (Flushing). At the time of the report, HYPOAESTHESIA (feeling numbness in her face), FEELING HOT (Felt warm feeling in her left cheek) and FLUSHING (Flushing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Patient was pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Patient was pregnant) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 09-Jul-2020 and the estimated date of delivery was 15-Apr-2021. On 25-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Patient was pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-seventh week of the pregnancy.  On 25-Mar-2021, EXPOSURE DURING PREGNANCY (Patient was pregnant) had resolved.            On 12-Aug-2020, the patient tested positive for pregnancy. Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: glands were swollen; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (glands were swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Celiac disease, Allergy and Asthma.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced LYMPHADENOPATHY (glands were swollen). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (glands were swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not reported.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Additional information received on 13-MAY-2021 Contains no new information
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation, Throat tightness
Clinical narrative: Within 4-5 minutes she felt her throat start to tighten,over couple hours got quite a bit worse around 1pm,felt different but still there and just as bad as before; Was really tightening and burning through the evening; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (Within 4-5 minutes she felt her throat start to tighten,over couple hours got quite a bit worse around 1pm,felt different but still there and just as bad as before) and THROAT IRRITATION (Was really tightening and burning through the evening) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HYDROXYCHLOROQUINE PHOSPHATE (PLAQUENIL [HYDROXYCHLOROQUINE PHOSPHATE]) and ETANERCEPT (ENBREL) for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced THROAT TIGHTNESS (Within 4-5 minutes she felt her throat start to tighten,over couple hours got quite a bit worse around 1pm,felt different but still there and just as bad as before) and THROAT IRRITATION (Was really tightening and burning through the evening). At the time of the report, THROAT TIGHTNESS (Within 4-5 minutes she felt her throat start to tighten,over couple hours got quite a bit worse around 1pm,felt different but still there and just as bad as before) and THROAT IRRITATION (Was really tightening and burning through the evening) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not receive any treatment medication.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Tested positive for Covid after receiving Moderna vaccine; This spontaneous case was reported by a nurse and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for Covid after receiving Moderna vaccine) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for Covid after receiving Moderna vaccine). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for Covid after receiving Moderna vaccine) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive for Covid-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product information was not provided. Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Peripheral swelling, Pyrexia, Stomatitis
Clinical narrative: canker sores on top of mouth and tongue; swollen fingers; swollen lymph nodes; fever; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of STOMATITIS (canker sores on top of mouth and tongue), PERIPHERAL SWELLING (swollen fingers), LYMPHADENOPATHY (swollen lymph nodes) and PYREXIA (fever) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced STOMATITIS (canker sores on top of mouth and tongue), PERIPHERAL SWELLING (swollen fingers), LYMPHADENOPATHY (swollen lymph nodes) and PYREXIA (fever). At the time of the report, STOMATITIS (canker sores on top of mouth and tongue), PERIPHERAL SWELLING (swollen fingers), LYMPHADENOPATHY (swollen lymph nodes) and PYREXIA (fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment medication included steroid.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse event, Fatigue, Muscle spasms, Myalgia, Pain in extremity
Clinical narrative: weird side effects; sore arm; kind of crampiness; general muscle ache; has been spiking very very low grade fever; achyness; a lot of fatigue; a lot of muscle aches; This spontaneous case was reported by a physician and describes the occurrence of ADVERSE EVENT, PAIN IN EXTREMITY, MUSCLE SPASMS, MYALGIA, and PYREXIA in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included SYNTHROID for Hyperthyroidism.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced ADVERSE EVENT, PAIN IN EXTREMITY, MUSCLE SPASMS, MYALGIA, PYREXIA, MYALGIA, FATIGUE, and MYALGIA. The patient was treated with TYLENOL for Ache, at an unspecified dose and frequency. At the time of the report, ADVERSE EVENT, PAIN IN EXTREMITY, MUSCLE SPASMS, MYALGIA, PYREXIA, MYALGIA, FATIGUE, and MYALGIA outcome was unknown. Not Provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had been spiking very low grade fever that comes and goes it had not gotten above 99.7. No concomitant medication was provided.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: weird side effects; sore arm; kind of crampiness; general muscle ache; has been spiking very very low grade fever; achyness; a lot of fatigue; a lot of muscle aches; This spontaneous case was reported by a physician and describes the occurrence of ADVERSE EVENT, PAIN IN EXTREMITY, MUSCLE SPASMS, MYALGIA, and PYREXIA in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included SYNTHROID for Hyperthyroidism.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced ADVERSE EVENT, PAIN IN EXTREMITY, MUSCLE SPASMS, MYALGIA, PYREXIA, MYALGIA, FATIGUE, and MYALGIA. The patient was treated with TYLENOL for Ache, at an unspecified dose and frequency. At the time of the report, ADVERSE EVENT, PAIN IN EXTREMITY, MUSCLE SPASMS, MYALGIA, PYREXIA, MYALGIA, FATIGUE, and MYALGIA outcome was unknown. Not Provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had been spiking very low grade fever that comes and goes it had not gotten above 99.7. No concomitant medication was provided.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Swelling
Clinical narrative: swelling of underarm and has armpit pain; swelling of underarm and has armpit pain; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling of underarm and has armpit pain) and AXILLARY PAIN (swelling of underarm and has armpit pain) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced SWELLING (swelling of underarm and has armpit pain) and AXILLARY PAIN (swelling of underarm and has armpit pain). At the time of the report, SWELLING (swelling of underarm and has armpit pain) and AXILLARY PAIN (swelling of underarm and has armpit pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Non significant follow up received on 14-May-2021 contains no new information.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and CHILLS (Chills) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced HEADACHE (Headache) and CHILLS (Chills). At the time of the report, HEADACHE (Headache) and CHILLS (Chills) outcome was unknown. Not Provided. For mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown), the reporter did not provide any causality assessments. Action taken with mRNA-1273 in response to the event was not applicable. No concomitant and treatment medication were provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: "soreness in my arm." after the first vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY ("soreness in my arm." after the first vaccine) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), IRBESARTAN (AVAPRO) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY ("soreness in my arm." after the first vaccine). At the time of the report, PAIN IN EXTREMITY ("soreness in my arm." after the first vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medication including supplements was reported.   This case was linked to MOD-2021-063865 (E2B Linked Report).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer (Patient's left breast removed because of breast cancer). Concomitant products included ANASTROZOLE, ATORVASTATIN, CARBIDOPA, LEVODOPA and LISINOPRIL for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (headache). On 30-Mar-2021, HEADACHE (headache) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Headache, Pain in extremity, Rash erythematous, Rash pruritic
Clinical narrative: tenderness , soreness which moved to the middle area of the upper arm , an irregular patch; an irregular patch , a big red rash which is slightly itchy/itchy red rash; cold trickle; an irregular patch , a big red rash which is slightly itchy/itchy red rash; Swelling/slightly raised like bump and hard; needling Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (tenderness , soreness which moved to the middle area of the upper arm , an irregular patch), RASH ERYTHEMATOUS (an irregular patch , a big red rash which is slightly itchy/itchy red rash), FEELING COLD (cold trickle), RASH PRURITIC (an irregular patch , a big red rash which is slightly itchy/itchy red rash) and SWELLING (Swelling/slightly raised like bump and hard) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (tenderness , soreness which moved to the middle area of the upper arm , an irregular patch), RASH ERYTHEMATOUS (an irregular patch , a big red rash which is slightly itchy/itchy red rash), FEELING COLD (cold trickle), RASH PRURITIC (an irregular patch , a big red rash which is slightly itchy/itchy red rash), SWELLING (Swelling/slightly raised like bump and hard) and HEADACHE (needling Headache). At the time of the report, PAIN IN EXTREMITY (tenderness , soreness which moved to the middle area of the upper arm , an irregular patch), RASH ERYTHEMATOUS (an irregular patch , a big red rash which is slightly itchy/itchy red rash), FEELING COLD (cold trickle), RASH PRURITIC (an irregular patch , a big red rash which is slightly itchy/itchy red rash), SWELLING (Swelling/slightly raised like bump and hard) and HEADACHE (needling Headache) outcome was unknown. Not Provided          Concomitant medication information was not reported. Treatment information as not reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: No new information was provided on 22-APR-2021.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: tenderness , soreness which moved to the middle area of the upper arm , an irregular patch; an irregular patch , a big red rash which is slightly itchy/itchy red rash; cold trickle; an irregular patch , a big red rash which is slightly itchy/itchy red rash; Swelling/slightly raised like bump and hard; needling Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (tenderness , soreness which moved to the middle area of the upper arm , an irregular patch), RASH ERYTHEMATOUS (an irregular patch , a big red rash which is slightly itchy/itchy red rash), FEELING COLD (cold trickle), RASH PRURITIC (an irregular patch , a big red rash which is slightly itchy/itchy red rash) and SWELLING (Swelling/slightly raised like bump and hard) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (tenderness , soreness which moved to the middle area of the upper arm , an irregular patch), RASH ERYTHEMATOUS (an irregular patch , a big red rash which is slightly itchy/itchy red rash), FEELING COLD (cold trickle), RASH PRURITIC (an irregular patch , a big red rash which is slightly itchy/itchy red rash), SWELLING (Swelling/slightly raised like bump and hard) and HEADACHE (needling Headache). At the time of the report, PAIN IN EXTREMITY (tenderness , soreness which moved to the middle area of the upper arm , an irregular patch), RASH ERYTHEMATOUS (an irregular patch , a big red rash which is slightly itchy/itchy red rash), FEELING COLD (cold trickle), RASH PRURITIC (an irregular patch , a big red rash which is slightly itchy/itchy red rash), SWELLING (Swelling/slightly raised like bump and hard) and HEADACHE (needling Headache) outcome was unknown. Not Provided          Concomitant medication information was not reported. Treatment information as not reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: No new information was provided on 22-APR-2021.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Paraesthesia, Pyrexia
Clinical narrative: Pain from the injection site down to her pointer and thumbs, pain as a tingling of pins and needles that will stay then go away; Pain in her arm which comes and goes; Fever; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (Pain in her arm which comes and goes ), PARAESTHESIA (Pain from the injection site down to her pointer and thumbs, pain as a tingling of pins and needles that will stay then go away) and PYREXIA (Fever) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 031M12A) for COVID-19 vaccination.     The patient's past medical history included Frozen shoulder (At first it was the patient's her left arm, however during the physical therapy the frozen shoulder then moved to her right arm. The patient iis alright now and recovered.) in 2020. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), ALENDRONATE SODIUM (ALENDRONATE), CYANOCOBALAMIN (VITAMIN B 12 [CYANOCOBALAMIN]) and COLECALCIFEROL (VITAMIN D 3) for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Fever). On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in her arm which comes and goes ). On 29-Mar-2021, the patient experienced PARAESTHESIA (Pain from the injection site down to her pointer and thumbs, pain as a tingling of pins and needles that will stay then go away). At the time of the report, PAIN IN EXTREMITY (Pain in her arm which comes and goes ), PARAESTHESIA (Pain from the injection site down to her pointer and thumbs, pain as a tingling of pins and needles that will stay then go away) and PYREXIA (Fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided. The patient states that if she is moving then she does not feel the tingling of pins and needles like pain, however if she is at rest the pins and needles come back. Sometimes the pain doesn't go directly down to the two fingers, it just goes down to the arm.   This case was linked to MOD-2021-037251 (Patient Link).
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Small amount of the vaccine ran down his left arm; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (Small amount of the vaccine ran down his left arm) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced UNDERDOSE (Small amount of the vaccine ran down his left arm). On 31-Mar-2021, UNDERDOSE (Small amount of the vaccine ran down his left arm) had resolved. Not Provided          Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant product use was not provided by the reporter. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: redness of left arm, which is itchy and swollen; redness of left arm, which is itchy and swollen; redness of left arm, which is itchy and swollen; left arm sore for a day and went away; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (redness of left arm, which is itchy and swollen), ERYTHEMA (redness of left arm, which is itchy and swollen), PERIPHERAL SWELLING (redness of left arm, which is itchy and swollen) and PAIN IN EXTREMITY (left arm sore for a day and went away) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (left arm sore for a day and went away). On 31-Mar-2021, the patient experienced PRURITUS (redness of left arm, which is itchy and swollen), ERYTHEMA (redness of left arm, which is itchy and swollen) and PERIPHERAL SWELLING (redness of left arm, which is itchy and swollen). On 24-Mar-2021, PAIN IN EXTREMITY (left arm sore for a day and went away) had resolved. At the time of the report, PRURITUS (redness of left arm, which is itchy and swollen), ERYTHEMA (redness of left arm, which is itchy and swollen) and PERIPHERAL SWELLING (redness of left arm, which is itchy and swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nausea
Clinical narrative: Patient had nausea for 2 days after receiving 2nd dose; Patient had chills for 2 days after receiving 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Patient had nausea for 2 days after receiving 2nd dose) and CHILLS (Patient had chills for 2 days after receiving 2nd dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NAUSEA (Patient had nausea for 2 days after receiving 2nd dose) and CHILLS (Patient had chills for 2 days after receiving 2nd dose). At the time of the report, NAUSEA (Patient had nausea for 2 days after receiving 2nd dose) and CHILLS (Patient had chills for 2 days after receiving 2nd dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The action taken with the drug in response to the events was not applicable.   This case was linked to MOD-2021-063834 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Updated reporter information.; Sender's Comments:  MOD-2021-063834:Daughter